✦ LIBER ✦

Sa1922 Superiority of Acid Suppression for Esomeprazole-Based Helicobacter pylori Eradication Therapy in Japanese CYP2C19 Rapid Metabolizers

✍ Scribed by Sahara, Shu; Sugimoto, Mitsushige; Horio, Yoshiaki; Uotani, Takahiro; Ichikawa, Hitomi; Yamade, Mihoko; Yamada, Takanori; Osawa, Satoshi; Sugimoto, Ken; Furuta, Takahisa

Book ID: 122323446
Publisher: Elsevier Science
Year: 2013
Tongue: English
Weight: 265 KB
Volume: 144
Category: Article
ISSN: 0016-5085
DOI: 10.1016/S0016-5085(13)61231-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Esomeprazole 40 mg twice daily in triple

Esomeprazole 40 mg twice daily in triple therapy and the efficacy of Helicobacter pylori eradication related to CYP2C19 metabolism

✍ B.-S. Sheu; A.-W. Kao; H.-C. Cheng; S.-F. Hunag; T.-W. Chen; C.-C. Lu; J.-J. Wu 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 68 KB

Efficacy and tolerability of first-line

Efficacy and tolerability of first-line triple therapy with levofloxacin and amoxicillin plus esomeprazole or rabeprazole for the eradication of Helicobacter pylori infection and the effect of CYP2C19 genotype: A 1-week, randomized, open-label study in chinese adults

✍ Xiaolin Pan; Yuqing Li; Yuping Qiu; Qiyun Tang; Bingbing Qian; Linhua Yao; Ruihu 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 117 KB